ストックスクリーナーアプリを入手
1.92
0.52%
0.01
アフターアワーズ：
2.00
0.08
+4.17%
前日終値:
$1.91
開ける：
$2.03
24時間の取引高:
483.48K
Relative Volume:
1.49
時価総額：
$69.02M
収益：
$210.70K
当期純損益:
$-21.37M
株価収益率:
-1.7455
EPS:
-1.1
ネットキャッシュフロー:
$-21.10M
1週間 パフォーマンス:
+3.23%
1か月 パフォーマンス:
+33.33%
6か月 パフォーマンス:
-1.54%
1年 パフォーマンス:
+84.62%
1日の値動き範囲:
$1.84
$2.0499
1週間の範囲:
$1.84
$2.0499
52週間の値動き範囲:
$1.00
$3.19
Gain Therapeutics Inc Stock (GANX) Company Profile
GANX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.92 | 71.54M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.23 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-12-06 | 開始されました | ROTH MKM | Buy |
| 2024-08-14 | 再開されました | Oppenheimer | Outperform |
| 2021-04-12 | 開始されました | BTIG Research | Buy |
| 2021-04-12 | 開始されました | Oppenheimer | Outperform |
Gain Therapeutics Inc (GANX) 最新ニュース
Ranking Gain Therapeutics Inc. among high performing stocks via toolsQuarterly Risk Review & Weekly Return Optimization Alerts - Newser
Forecasting Gain Therapeutics Inc. price range with options dataJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
What indicators show strength in Gain Therapeutics Inc.Market Sentiment Review & Free Safe Capital Growth Stock Tips - Newser
What’s next for Gain Therapeutics Inc. stock priceTrade Entry Report & Accurate Technical Buy Alerts - Newser
Analyzing recovery setups for Gain Therapeutics Inc. investors2025 Performance Recap & Risk Controlled Daily Plans - Newser
Visualizing Gain Therapeutics Inc. stock with heatmaps2025 Volume Leaders & Technical Confirmation Trade Alerts - Newser
Price action breakdown for Gain Therapeutics Inc.IPO Watch & Community Driven Trade Alerts - Newser
Gain Therapeutics Inc. recovery potential after sell offWeekly Trade Report & Technical Confirmation Trade Alerts - Newser
Is a relief rally coming for Gain Therapeutics Inc. holdersMarket Performance Report & Free Real-Time Volume Trigger Notifications - Newser
Using Ichimoku Cloud for Gain Therapeutics Inc. technicalsDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Live market analysis of Gain Therapeutics Inc.2025 Geopolitical Influence & Consistent Profit Trade Alerts - Newser
How to use a screener to detect Gain Therapeutics Inc. breakoutsTrade Volume Report & Risk Controlled Daily Trade Plans - Newser
Is this a good reentry point in Gain Therapeutics Inc.July 2025 Sentiment & Long-Term Safe Investment Plans - Newser
Real time alert setup for Gain Therapeutics Inc. performance2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
Gain Therapeutics: Targeting Parkinson’s at the Cellular Level - The Globe and Mail
Gain Therapeutics: Advancing Science in the Fight Against Parkinson’s - The Globe and Mail
Is Gain Therapeutics Inc. stock showing strong momentum2025 Biggest Moves & Weekly Return Optimization Plans - khodrobank.com
What drives Gain Therapeutics Inc.’s stock pricePrice Action & Weekly Top Performers Watchlists - khodrobank.com
Is Gain Therapeutics Inc. benefiting from innovation trendsM&A Rumor & Daily Technical Stock Forecast Reports - khodrobank.com
Performance Recap: What drives Gain Therapeutics Inc.’s stock priceMarket Activity Summary & Safe Capital Growth Tips - khodrobank.com
Is now a turning point for Gain Therapeutics Inc.Market Risk Summary & Stepwise Trade Execution Plans - Newser
What data driven models say about Gain Therapeutics Inc.’s futureWall Street Watch & Verified Trade Idea Suggestions - Newser
Parkinson’s Disease Pipeline Analysis, 2025 by DelveInsight | Annovis Bio, Cerevel Therapeutics, Roche, Inhibikase Therapeutics, Inc, Gain Therapeutics, Neuronascent, ANEW MEDICAL, Longevity Biotech, - Barchart.com
Real time social sentiment graph for Atossa Therapeutics Inc.Weekly Gains Summary & Breakout Confirmation Trade Signals - Newser
How institutional ownership impacts Gain Therapeutics Inc. stockMarket Movement Recap & AI Driven Stock Price Forecasts - Newser
Can Gain Therapeutics Inc. reach resistance levels soon2025 Breakouts & Breakdowns & Fast Moving Market Watchlists - خودرو بانک
Will breakout in Gain Therapeutics Inc. lead to full recovery2025 Risk Factors & Accurate Intraday Trade Tips - Newser
What the charts say about Gain Therapeutics Inc. today2025 Market Sentiment & Breakout Confirmation Trade Signals - Newser
Is Gain Therapeutics Inc. showing signs of accumulationTrade Analysis Summary & Capital Efficiency Focused Strategies - Newser
Developing predictive dashboards with Gain Therapeutics Inc. data2025 Support & Resistance & Stock Market Timing Techniques - Newser
Gain Therapeutics Inc.’s volatility index tracking explainedWeekly Risk Summary & Daily Profit Focused Screening - Newser
MACD Signals Flash Warning for Gain Therapeutics Inc. StockWeekly Stock Analysis & Scalable Portfolio Growth Ideas - beatles.ru
Visual trend scoring systems applied to Gain Therapeutics Inc.Fed Meeting & Growth Focused Stock Pick Reports - Newser
Leading vs lagging indicators on Actuate Therapeutics Inc. performanceGold Moves & Detailed Earnings Play Alerts - Newser
Gain Therapeutics Inc. stock volume spike explainedJuly 2025 Analyst Calls & Safe Capital Allocation Plans - Newser
Does XORTX Therapeutics Inc. fit your quant trading modelMarket Weekly Review & Daily Entry Point Alerts - Newser
Key resistance and support levels for Gain Therapeutics Inc.2025 Biggest Moves & AI Powered Market Entry Strategies - Newser
Gain Therapeutics Inc (GANX) 財務データ
収益
当期純利益
現金流量
EPS
1.14%
1.34%
大文字化:
|
ボリューム (24 時間):